Peptide science, reviewed for clinicians
Evidence-graded topic guides, mechanism explainers, and clinical considerations — written and reviewed by credentialed professionals. No sales. No dosing protocols. No claims on unapproved compounds.
published
About this resource
Built for clinical decision-making, not marketing
What this site is
- Evidence-graded topic guides with primary citations
- Mechanism of action explainers for peptide classes
- Regulatory status and safety signal tracking
- Clinic referral directory for patient handoff
- Honest flagging of contested or insufficient evidence
What you will not find here
- Product sales or links to peptide suppliers
- Dosing protocols for unapproved compounds
- Before/after imagery or patient testimonials
- Therapeutic claims unsupported by published evidence
- Affiliate relationships or sponsored content
Evidence methodology
How we grade confidence
Multiple well-designed RCTs with consistent results in relevant populations.
RCTs with limitations, or strong observational data with biological plausibility.
Small trials, case series, or extrapolation from related compounds.
Mechanistic or animal data only. No controlled human evidence for the stated use.
Evidence library
Topic guides
Gastric pentadecapeptide. Pre-clinical evidence in tissue repair; no completed human RCTs for injectable use.
43-amino acid peptide involved in actin sequestration. Animal models suggest wound-healing effects; human evidence limited to case series.
Copper-binding tripeptide with topical applications in wound healing. Some controlled human data for dermal use.
GLP-1 receptor agonist. Extensive Phase III data for glycemic control and weight management. FDA-approved.
Modified GHRH analog. Published human pharmacokinetic data; efficacy evidence limited to single-dose studies.
Melanocortin receptor agonist. FDA-approved for HSDD. Phase III trial data available.
Editorial board
Reviewed by specialists, not marketers
Every guide carries a named reviewer byline. Our advisory board includes board-certified physicians and clinical researchers.
Latest insights
Clinical perspectives, evidence updates, and regulatory developments — by our editorial team.
Follow the conversation
Evidence-first commentary across platforms. No supplement promotion, no before/afters.